Antiretroviral Drug Market
Antiretroviral Drug Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Antiretroviral Drug Market Size and Growth
The Antiretroviral Drug market is experiencing robust growth, driven by increasing HIV prevalence and advancements in treatment. The global market size was valued at approximately $30 billion in 2023, with a projected CAGR of around 6% through 2030. Key trends include generic drug adoption and enhanced treatment accessibility in developing regions. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Gilead Sciences
◍ ViiV Healthcare
◍ Bristol-Myer Squibb
◍ AbbVie
◍ Boehringer-Ingelheim
◍ Johnson and Johnson
◍ Merck
◍ CIPLA
The antiretroviral drug market features key players like Gilead Sciences, ViiV Healthcare, Bristol-Myers Squibb, and others. These companies drive market growth through innovative drug development, strategic partnerships, and global access initiatives.
Notable sales revenue figures include:
- Gilead Sciences: ~$26 billion
- Merck: ~$21 billion
- AbbVie: ~$22 billion.
Request Sample Report
Market Segmentation
By Application
Hospital
Pharmaceutical Companies
Other
By Product
◍ Multi-Class Drugs Combination ◍ NRTI
NNRTI
Protease Inhibitors
Other
Request Sample Report
$ 99.64 Billion
Request Sample Report
